Nucleic Acid Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035

TMR's report on the global nucleic acid therapeutics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global nucleic acid therapeutics market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global nucleic acid therapeutics market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the nucleic acid therapeutics market.

Market Snapshot
Market Value in 2024	US$ 8.8 Bn
Market Value in 2035	US$ 44.5 Bn
CAGR	14.7%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global nucleic acid therapeutics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global nucleic acid therapeutics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global nucleic acid therapeutics market.

The report delves into the competitive landscape of the global nucleic acid therapeutics market. Key players operating in the global nucleic acid therapeutics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global nucleic acid therapeutics market profiled in this report.

Key Questions Answered in Global nucleic acid therapeutics market Report:

What is the sales/revenue generated by nucleic acid therapeutics across all regions during the forecast period?
What are the opportunities in the global nucleic acid therapeutics market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2035?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?

Nucleic Acid Therapeutics Market - Research Objectives and Research Approach

The comprehensive report on the global nucleic acid therapeutics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global nucleic acid therapeutics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global nucleic acid therapeutics market.

Product Code: TMRGL86333

1. Preface

1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Nucleic Acid Therapeutics Market

4. Market Overview

4.1. Introduction
- 4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
4.4. Global Nucleic Acid Therapeutics Market Analysis and Forecast, 2020 - 2035
- 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

5.1. Healthcare Expenditure across Key Regions / Countries
5.2. Technological Advancements in Nucleic Acid Therapeutics Industry
5.3. List of Nucleic Acid Therapeutics Approved by FDA
5.4. Nucleic Acid Therapeutics Pricing Trends
5.5. Nucleic Acid Therapeutics: Clinical Trial Analysis
5.6. Funding and Investments Analysis
5.7. PORTER's Five Forces Analysis
5.8. Regulatory Landscape across Key Regions / Countries
5.9. Go-to-Market Strategy for New Market Entrants
5.10. Key Purchase Metrics for End-users
5.11. Key Industry Events (Partnership, Collaborations, Product approvals, merger & acquisitions)
5.12. Benchmarking of the Products Offered by the Leading Competitors
5.13. Preclinical Pipeline Analysis for Nucleic Acid Therapeutics

6. Global Nucleic Acid Therapeutics Market Analysis and Forecast, by Therapy Type

6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Therapy Type, 2020 - 2035
- 6.3.1. Antisense oligonucleotides (ASOs)
- 6.3.2. Small interfering R(siRNA)
- 6.3.3. Gene Therapies
- 6.3.4. Aptamers
- 6.3.5. Others
6.4. Market Attractiveness Analysis, by Therapy Type

7. Global Nucleic Acid Therapeutics Market Analysis and Forecast, by Delivery Method

7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Delivery Method, 2020 - 2035
- 7.3.1. Viral vector-based Delivery Systems
- 7.3.2. Non-viral Delivery Systems
7.4. Market Attractiveness Analysis, by Delivery Method

8. Global Nucleic Acid Therapeutics Market Analysis and Forecast, by Route of Administration

8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Route of Administration, 2020 - 2035
- 8.3.1. Intravenous
- 8.3.2. Subcutaneous
- 8.3.3. Others
8.4. Market Attractiveness Analysis, by Route of Administration

9. Global Nucleic Acid Therapeutics Market Analysis and Forecast, by Therapeutic Area

9.1. Introduction & Definition
9.2. Key Findings/Developments
9.3. Market Value Forecast, by Therapeutic Area, 2020 - 2035
- 9.3.1. Neuromuscular Disorder
- 9.3.2. Metabolic Disorders
- 9.3.3. Cardiovascular Disorders
- 9.3.4. Ophthalmological Disorders
- 9.3.5. Oncological Disorders
- 9.3.6. Others
9.4. Market Attractiveness Analysis, by Therapeutic Area

10. Global Nucleic Acid Therapeutics Market Analysis and Forecast, by End-user

10.1. Introduction & Definition
10.2. Key Findings/Developments
10.3. Market Value Forecast, by End-user, 2020 - 2035
- 10.3.1. Hospitals
- 10.3.2. Academic and Research Institutes
- 10.3.3. Others
10.4. Market Attractiveness Analysis, by End-user

11. Global Nucleic Acid Therapeutics Market Analysis and Forecast, by Region

11.1. Key Findings
11.2. Market Value Forecast, by Region, 2020 - 2035
- 11.2.1. North America
- 11.2.2. Europe
- 11.2.3. Asia Pacific
- 11.2.4. Latin America
- 11.2.5. Middle East & Africa
11.3. Market Attractiveness Analysis, by Region

12. North America Nucleic Acid Therapeutics Market Analysis and Forecast

12.1. Introduction
- 12.1.1. Key Findings
12.2. Market Value Forecast, by Therapy Type, 2020 - 2035
- 12.2.1. Antisense oligonucleotides (ASOs)
- 12.2.2. Small interfering R(siRNA)
- 12.2.3. Gene Therapies
- 12.2.4. Aptamers
- 12.2.5. Others
12.3. Market Value Forecast, by Delivery Method, 2020 - 2035
- 12.3.1. Viral vector-based Delivery Systems
- 12.3.2. Non-viral Delivery Systems
12.4. Market Value Forecast, by Route of Administration, 2020 - 2035
- 12.4.1. Intravenous
- 12.4.2. Subcutaneous
- 12.4.3. Others
12.5. Market Value Forecast, by Therapeutic Area, 2020 - 2035
- 12.5.1. Neuromuscular Disorder
- 12.5.2. Metabolic Disorders
- 12.5.3. Cardiovascular Disorders
- 12.5.4. Ophthalmological Disorders
- 12.5.5. Oncological Disorders
- 12.5.6. Others
12.6. Market Value Forecast, by End-user, 2020 - 2035
- 12.6.1. Hospitals
- 12.6.2. Academic and Research Institutes
- 12.6.3. Others
12.7. Market Value Forecast, by Country, 2020 - 2035
- 12.7.1. U.S.
- 12.7.2. Canada
12.8. Market Attractiveness Analysis
- 12.8.1. By Therapy Type
- 12.8.2. By Delivery Method
- 12.8.3. By Route of Administration
- 12.8.4. By Therapeutic Area
- 12.8.5. By End-user
- 12.8.6. By Country

13. Europe Nucleic Acid Therapeutics Market Analysis and Forecast

13.1. Introduction
- 13.1.1. Key Findings
13.2. Market Value Forecast, by Therapy Type, 2020 - 2035
- 13.2.1. Antisense oligonucleotides (ASOs)
- 13.2.2. Small interfering R(siRNA)
- 13.2.3. Gene Therapies
- 13.2.4. Aptamers
- 13.2.5. Others
13.3. Market Value Forecast, by Delivery Method, 2020 - 2035
- 13.3.1. Viral vector-based Delivery Systems
- 13.3.2. Non-viral Delivery Systems
13.4. Market Value Forecast, by Route of Administration, 2020 - 2035
- 13.4.1. Intravenous
- 13.4.2. Subcutaneous
- 13.4.3. Others
13.5. Market Value Forecast, by Therapeutic Area, 2020 - 2035
- 13.5.1. Neuromuscular Disorder
- 13.5.2. Metabolic Disorders
- 13.5.3. Cardiovascular Disorders
- 13.5.4. Ophthalmological Disorders
- 13.5.5. Oncological Disorders
- 13.5.6. Others
13.6. Market Value Forecast, by End-user, 2020 - 2035
- 13.6.1. Hospitals
- 13.6.2. Academic and Research Institutes
- 13.6.3. Others
13.7. Market Value Forecast, by Country/Sub-region, 2020 - 2035
- 13.7.1. Germany
- 13.7.2. UK
- 13.7.3. France
- 13.7.4. Italy
- 13.7.5. Spain
- 13.7.6. Rest of Europe
13.8. Market Attractiveness Analysis
- 13.8.1. By Therapy Type
- 13.8.2. By Delivery Method
- 13.8.3. By Route of Administration
- 13.8.4. By Therapeutic Area
- 13.8.5. By End-user
- 13.8.6. By Country/Sub-region

14. Asia Pacific Nucleic Acid Therapeutics Market Analysis and Forecast

14.1. Introduction
- 14.1.1. Key Findings
14.2. Market Value Forecast, by Therapy Type, 2020 - 2035
- 14.2.1. Antisense oligonucleotides (ASOs)
- 14.2.2. Small interfering R(siRNA)
- 14.2.3. Gene Therapies
- 14.2.4. Aptamers
- 14.2.5. Others
14.3. Market Value Forecast, by Delivery Method, 2020 - 2035
- 14.3.1. Viral vector-based Delivery Systems
- 14.3.2. Non-viral Delivery Systems
14.4. Market Value Forecast, by Route of Administration, 2020 - 2035
- 14.4.1. Intravenous
- 14.4.2. Subcutaneous
- 14.4.3. Others
14.5. Market Value Forecast, by Therapeutic Area, 2020 - 2035
- 14.5.1. Neuromuscular Disorder
- 14.5.2. Metabolic Disorders
- 14.5.3. Cardiovascular Disorders
- 14.5.4. Ophthalmological Disorders
- 14.5.5. Oncological Disorders
- 14.5.6. Others
14.6. Market Value Forecast, by End-user, 2020 - 2035
- 14.6.1. Hospitals
- 14.6.2. Academic and Research Institutes
- 14.6.3. Others
14.7. Market Value Forecast, by Country/Sub-region, 2020 - 2035
- 14.7.1. China
- 14.7.2. Japan
- 14.7.3. India
- 14.7.4. Australia & New Zealand
- 14.7.5. Rest of Asia Pacific
14.8. Market Attractiveness Analysis
- 14.8.1. By Therapy Type
- 14.8.2. By Delivery Method
- 14.8.3. By Route of Administration
- 14.8.4. By Therapeutic Area
- 14.8.5. By End-user
- 14.8.6. By Country/Sub-region

15. Latin America Nucleic Acid Therapeutics Market Analysis and Forecast

15.1. Introduction
- 15.1.1. Key Findings
15.2. Market Value Forecast, by Therapy Type, 2020 - 2035
- 15.2.1. Antisense oligonucleotides (ASOs)
- 15.2.2. Small interfering R(siRNA)
- 15.2.3. Gene Therapies
- 15.2.4. Aptamers
- 15.2.5. Others
15.3. Market Value Forecast, by Delivery Method, 2020 - 2035
- 15.3.1. Viral vector-based Delivery Systems
- 15.3.2. Non-viral Delivery Systems
15.4. Market Value Forecast, by Route of Administration, 2020 - 2035
- 15.4.1. Intravenous
- 15.4.2. Subcutaneous
- 15.4.3. Others
15.5. Market Value Forecast, by Therapeutic Area, 2020 - 2035
- 15.5.1. Neuromuscular Disorder
- 15.5.2. Metabolic Disorders
- 15.5.3. Cardiovascular Disorders
- 15.5.4. Ophthalmological Disorders
- 15.5.5. Oncological Disorders
- 15.5.6. Others
15.6. Market Value Forecast, by End-user, 2020 - 2035
- 15.6.1. Hospitals
- 15.6.2. Academic and Research Institutes
- 15.6.3. Others
15.7. Market Value Forecast, by Country/Sub-region, 2020 - 2035
- 15.7.1. Brazil
- 15.7.2. Mexico
- 15.7.3. Rest of Latin America
15.8. Market Attractiveness Analysis
- 15.8.1. By Therapy Type
- 15.8.2. By Delivery Method
- 15.8.3. By Route of Administration
- 15.8.4. By Therapeutic Area
- 15.8.5. By End-user
- 15.8.6. By Country/Sub-region

16. Middle East & Africa Nucleic Acid Therapeutics Market Analysis and Forecast

16.1. Introduction
- 16.1.1. Key Findings
16.2. Market Value Forecast, by Therapy Type, 2020 - 2035
- 16.2.1. Antisense oligonucleotides (ASOs)
- 16.2.2. Small interfering R(siRNA)
- 16.2.3. Gene Therapies
- 16.2.4. Aptamers
- 16.2.5. Others
16.3. Market Value Forecast, by Delivery Method, 2020 - 2035
- 16.3.1. Viral vector-based Delivery Systems
- 16.3.2. Non-viral Delivery Systems
16.4. Market Value Forecast, by Route of Administration, 2020 - 2035
- 16.4.1. Intravenous
- 16.4.2. Subcutaneous
- 16.4.3. Others
16.5. Market Value Forecast, by Therapeutic Area, 2020 - 2035
- 16.5.1. Neuromuscular Disorder
- 16.5.2. Metabolic Disorders
- 16.5.3. Cardiovascular Disorders
- 16.5.4. Ophthalmological Disorders
- 16.5.5. Oncological Disorders
- 16.5.6. Others
16.6. Market Value Forecast, by End-user, 2020 - 2035
- 16.6.1. Hospitals
- 16.6.2. Academic and Research Institutes
- 16.6.3. Others
16.7. Market Value Forecast, by Country/Sub-region, 2020 - 2035
- 16.7.1. GCC Countries
- 16.7.2. South Africa
- 16.7.3. Rest of Middle East & Africa
16.8. Market Attractiveness Analysis
- 16.8.1. By Therapy Type
- 16.8.2. By Delivery Method
- 16.8.3. By Route of Administration
- 16.8.4. By Therapeutic Area
- 16.8.5. By End-user
- 16.8.6. By Country/Sub-region

17. Competition Landscape

17.1. Market Player - Competition Matrix (By Tier and Size of companies)
17.2. Market Share Analysis, by Company (2024)
17.3. Company Profiles
- 17.3.1. Novartis AG
  - 17.3.1.1. Company Overview
  - 17.3.1.2. Financial Overview
  - 17.3.1.3. Product Portfolio
  - 17.3.1.4. Business Strategies
  - 17.3.1.5. Recent Developments
- 17.3.2. Pfizer, Inc.
  - 17.3.2.1. Company Overview
  - 17.3.2.2. Financial Overview
  - 17.3.2.3. Product Portfolio
  - 17.3.2.4. Business Strategies
  - 17.3.2.5. Recent Developments
- 17.3.3. Sanofi
  - 17.3.3.1. Company Overview
  - 17.3.3.2. Financial Overview
  - 17.3.3.3. Product Portfolio
  - 17.3.3.4. Business Strategies
  - 17.3.3.5. Recent Developments
- 17.3.4. Novo Nordisk A/S
  - 17.3.4.1. Company Overview
  - 17.3.4.2. Financial Overview
  - 17.3.4.3. Product Portfolio
  - 17.3.4.4. Business Strategies
  - 17.3.4.5. Recent Developments
- 17.3.5. AstraZeneca plc
  - 17.3.5.1. Company Overview
  - 17.3.5.2. Financial Overview
  - 17.3.5.3. Product Portfolio
  - 17.3.5.4. Business Strategies
  - 17.3.5.5. Recent Developments
- 17.3.6. Alnylam Pharmaceuticals, Inc.
  - 17.3.6.1. Company Overview
  - 17.3.6.2. Financial Overview
  - 17.3.6.3. Product Portfolio
  - 17.3.6.4. Business Strategies
  - 17.3.6.5. Recent Developments
- 17.3.7. Amgen Inc
  - 17.3.7.1. Company Overview
  - 17.3.7.2. Financial Overview
  - 17.3.7.3. Product Portfolio
  - 17.3.7.4. Business Strategies
  - 17.3.7.5. Recent Developments
- 17.3.8. Sarepta Therapeutics, Inc.
  - 17.3.8.1. Company Overview
  - 17.3.8.2. Financial Overview
  - 17.3.8.3. Product Portfolio
  - 17.3.8.4. Business Strategies
  - 17.3.8.5. Recent Developments
- 17.3.9. Bluebird Bio, Inc
  - 17.3.9.1. Company Overview
  - 17.3.9.2. Financial Overview
  - 17.3.9.3. Product Portfolio
  - 17.3.9.4. Business Strategies
  - 17.3.9.5. Recent Developments
- 17.3.10. CSL Behring LLC
  - 17.3.10.1. Company Overview
  - 17.3.10.2. Financial Overview
  - 17.3.10.3. Product Portfolio
  - 17.3.10.4. Business Strategies
  - 17.3.10.5. Recent Developments
- 17.3.11. Ferring Pharmaceuticals Inc.
  - 17.3.11.1. Company Overview
  - 17.3.11.2. Financial Overview
  - 17.3.11.3. Product Portfolio
  - 17.3.11.4. Business Strategies
  - 17.3.11.5. Recent Developments
- 17.3.12. Krystal Biotech, Inc.
  - 17.3.12.1. Company Overview
  - 17.3.12.2. Financial Overview
  - 17.3.12.3. Product Portfolio
  - 17.3.12.4. Business Strategies
  - 17.3.12.5. Recent Developments
- 17.3.13. PTC Therapeutics, Inc.
  - 17.3.13.1. Company Overview
  - 17.3.13.2. Financial Overview
  - 17.3.13.3. Product Portfolio
  - 17.3.13.4. Business Strategies
  - 17.3.13.5. Recent Developments
- 17.3.14. Jazz Pharmaceuticals plc
  - 17.3.14.1. Company Overview
  - 17.3.14.2. Financial Overview
  - 17.3.14.3. Product Portfolio
  - 17.3.14.4. Business Strategies
  - 17.3.14.5. Recent Developments
- 17.3.15. Astellas Pharma Inc.
  - 17.3.15.1. Company Overview
  - 17.3.15.2. Financial Overview
  - 17.3.15.3. Product Portfolio
  - 17.3.15.4. Business Strategies
  - 17.3.15.5. Recent Developments

Product Code: TMRGL86333

List of Tables

Table 01: Global Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, By Therapy Type, 2020 - 2035
Table 02: Global Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, By Delivery Method, 2020 - 2035
Table 03: Global Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, By Route of Administration, 2020 - 2035
Table 04: Global Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, By Therapeutic Area, 2020 - 2035
Table 05: Global Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, By End-user, 2020 - 2035
Table 06: Global Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, By Region, 2020 - 2035
Table 07: North America Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by Country, 2020-2035
Table 08: North America Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, By Therapy Type, 2020 - 2035
Table 09: North America Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, By Delivery Method, 2020 - 2035
Table 10: North America Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, By Route of Administration, 2020 - 2035
Table 11: North America Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, By Therapeutic Area, 2020 - 2035
Table 12: North America Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, By End-user, 2020 - 2035
Table 13: Europe Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by Country / Sub-region, 2020-2035
Table 14: Europe Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, By Therapy Type, 2020 - 2035
Table 15: Europe Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, By Delivery Method, 2020 - 2035
Table 16: Europe Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, By Route of Administration, 2020 - 2035
Table 17: Europe Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, By Therapeutic Area, 2020 - 2035
Table 18: Europe Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, By End-user, 2020 - 2035
Table 19: Asia Pacific Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by Country / Sub-region, 2020-2035
Table 20: Asia Pacific Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, By Therapy Type, 2020 - 2035
Table 21: Asia Pacific Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, By Delivery Method, 2020 - 2035
Table 22: Asia Pacific Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, By Route of Administration, 2020 - 2035
Table 23: Asia Pacific Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, By Therapeutic Area, 2020 - 2035
Table 24: Asia Pacific Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, By End-user, 2020 - 2035
Table 25: Latin America Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by Country / Sub-region, 2020-2035
Table 26: Latin America Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, By Therapy Type, 2020 - 2035
Table 27: Latin America Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, By Delivery Method, 2020 - 2035
Table 28: Latin America Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, By Route of Administration, 2020 - 2035
Table 29: Latin America Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, By Therapeutic Area, 2020 - 2035
Table 30: Latin America Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, By End-user, 2020 - 2035
Table 31: Middle East & Africa Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by Country / Sub-region, 2020-2035
Table 32: Middle East & Africa Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, By Therapy Type, 2020 - 2035
Table 33: Middle East & Africa Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, By Delivery Method, 2020 - 2035
Table 34: Middle East & Africa Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, By Route of Administration, 2020 - 2035
Table 35: Middle East & Africa Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, By Therapeutic Area, 2020 - 2035
Table 36: Middle East & Africa Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, By End-user, 2020 - 2035

List of Figures

Figure 01: Global Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, 2020 - 2035
Figure 02: Global Nucleic Acid Therapeutics Market Value Share Analysis, By Therapy Type, 2024 and 2035
Figure 03: Global Nucleic Acid Therapeutics Market Attractiveness Analysis, By Therapy Type, 2025 - 2035
Figure 04: Global Nucleic Acid Therapeutics Market Revenue (US$ Mn), by Antisense oligonucleotides (ASOs), 2020 - 2035
Figure 05: Global Nucleic Acid Therapeutics Market Revenue (US$ Mn), by Small interfering RNA (siRNA), 2020 - 2035
Figure 06: Global Nucleic Acid Therapeutics Market Revenue (US$ Mn), by Gene Therapies, 2020 - 2035
Figure 07: Global Nucleic Acid Therapeutics Market Revenue (US$ Mn), by Aptamers, 2020 - 2035
Figure 08: Global Nucleic Acid Therapeutics Market Revenue (US$ Mn), by Others, 2020 - 2035
Figure 09: Global Nucleic Acid Therapeutics Market Value Share Analysis, By Delivery Method, 2024 and 2035
Figure 10: Global Nucleic Acid Therapeutics Market Attractiveness Analysis, By Delivery Method, 2025 - 2035
Figure 11: Global Nucleic Acid Therapeutics Market Revenue (US$ Mn), by Viral vector-based Delivery Systems, 2020 - 2035
Figure 12: Global Nucleic Acid Therapeutics Market Revenue (US$ Mn), by Non-viral Delivery Systems, 2020 - 2035
Figure 13: Global Nucleic Acid Therapeutics Market Value Share Analysis, By Route of Administration, 2024 and 2035
Figure 14: Global Nucleic Acid Therapeutics Market Attractiveness Analysis, By Route of Administration, 2025 - 2035
Figure 15: Global Nucleic Acid Therapeutics Market Revenue (US$ Mn), by Intravenous, 2020 - 2035
Figure 16: Global Nucleic Acid Therapeutics Market Revenue (US$ Mn), by Subcutaneous, 2020 - 2035
Figure 17: Global Nucleic Acid Therapeutics Market Revenue (US$ Mn), by Others, 2020 - 2035
Figure 18: Global Nucleic Acid Therapeutics Market Value Share Analysis, By Therapeutic Area, 2024 and 2035
Figure 19: Global Nucleic Acid Therapeutics Market Attractiveness Analysis, By Therapeutic Area, 2025 - 2035
Figure 20: Global Nucleic Acid Therapeutics Market Revenue (US$ Mn), by Neuromuscular Disorder, 2020 - 2035
Figure 21: Global Nucleic Acid Therapeutics Market Revenue (US$ Mn), by Metabolic Disorders, 2020 - 2035
Figure 22: Global Nucleic Acid Therapeutics Market Revenue (US$ Mn), by Cardiovascular Disorders, 2020 - 2035
Figure 23: Global Nucleic Acid Therapeutics Market Revenue (US$ Mn), by Ophthalmological Disorders, 2020 - 2035
Figure 24: Global Nucleic Acid Therapeutics Market Revenue (US$ Mn), by Oncological Disorders, 2020 - 2035
Figure 25: Global Nucleic Acid Therapeutics Market Revenue (US$ Mn), by Others, 2020 - 2035
Figure 26: Global Nucleic Acid Therapeutics Market Value Share Analysis, By End-user, 2024 and 2035
Figure 27: Global Nucleic Acid Therapeutics Market Attractiveness Analysis, By End-user, 2025 - 2035
Figure 28: Global Nucleic Acid Therapeutics Market Revenue (US$ Mn), by Hospitals, 2020 - 2035
Figure 29: Global Nucleic Acid Therapeutics Market Revenue (US$ Mn), by Academic and Research Institutes, 2020 - 2035
Figure 30: Global Nucleic Acid Therapeutics Market Revenue (US$ Mn), by Others, 2020 - 2035
Figure 31: Global Nucleic Acid Therapeutics Market Value Share Analysis, By Region, 2024 and 2035
Figure 32: Global Nucleic Acid Therapeutics Market Attractiveness Analysis, By Region, 2025 - 2035
Figure 33: North America Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, 2020 - 2035
Figure 34: North America Nucleic Acid Therapeutics Market Value Share Analysis, by Country, 2024 and 2035
Figure 35: North America Nucleic Acid Therapeutics Market Attractiveness Analysis, by Country, 2025 - 2035
Figure 36: North America Nucleic Acid Therapeutics Market Value Share Analysis, By Therapy Type, 2024 and 2035
Figure 37: North America Nucleic Acid Therapeutics Market Attractiveness Analysis, By Therapy Type, 2025 - 2035
Figure 38: North America Nucleic Acid Therapeutics Market Value Share Analysis, By Delivery Method, 2024 and 2035
Figure 39: North America Nucleic Acid Therapeutics Market Attractiveness Analysis, By Delivery Method, 2025 - 2035
Figure 40: North America Nucleic Acid Therapeutics Market Value Share Analysis, By Route of Administration, 2024 and 2035
Figure 41: North America Nucleic Acid Therapeutics Market Attractiveness Analysis, By Route of Administration, 2025 - 2035
Figure 42: North America Nucleic Acid Therapeutics Market Value Share Analysis, By Therapeutic Area, 2024 and 2035
Figure 43: North America Nucleic Acid Therapeutics Market Attractiveness Analysis, By Therapeutic Area, 2025 - 2035
Figure 44: North America Nucleic Acid Therapeutics Market Value Share Analysis, By End-user, 2024 and 2035
Figure 45: North America Nucleic Acid Therapeutics Market Attractiveness Analysis, By End-user, 2025 - 2035
Figure 46: Europe Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, 2020 - 2035
Figure 47: Europe Nucleic Acid Therapeutics Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
Figure 48: Europe Nucleic Acid Therapeutics Market Attractiveness Analysis, by Country / Sub-region, 2025 - 2035
Figure 49: Europe Nucleic Acid Therapeutics Market Value Share Analysis, By Therapy Type, 2024 and 2035
Figure 50: Europe Nucleic Acid Therapeutics Market Attractiveness Analysis, By Therapy Type, 2025 - 2035
Figure 51: Europe Nucleic Acid Therapeutics Market Value Share Analysis, By Delivery Method, 2024 and 2035
Figure 52: Europe Nucleic Acid Therapeutics Market Attractiveness Analysis, By Delivery Method, 2025 - 2035
Figure 53: Europe Nucleic Acid Therapeutics Market Value Share Analysis, By Route of Administration, 2024 and 2035
Figure 54: Europe Nucleic Acid Therapeutics Market Attractiveness Analysis, By Route of Administration, 2025 - 2035
Figure 55: Europe Nucleic Acid Therapeutics Market Value Share Analysis, By Therapeutic Area, 2024 and 2035
Figure 56: Europe Nucleic Acid Therapeutics Market Attractiveness Analysis, By Therapeutic Area, 2025 - 2035
Figure 57: Europe Nucleic Acid Therapeutics Market Value Share Analysis, By End-user, 2024 and 2035
Figure 58: Europe Nucleic Acid Therapeutics Market Attractiveness Analysis, By End-user, 2025 - 2035
Figure 59: Asia Pacific Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, 2020 - 2035
Figure 60: Asia Pacific Nucleic Acid Therapeutics Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
Figure 61: Asia Pacific Nucleic Acid Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2025 - 2035
Figure 62: Asia Pacific Nucleic Acid Therapeutics Market Value Share Analysis, By Therapy Type, 2024 and 2035
Figure 63: Asia Pacific Nucleic Acid Therapeutics Market Attractiveness Analysis, By Therapy Type, 2025 - 2035
Figure 64: Asia Pacific Nucleic Acid Therapeutics Market Value Share Analysis, By Delivery Method, 2024 and 2035
Figure 65: Asia Pacific Nucleic Acid Therapeutics Market Attractiveness Analysis, By Delivery Method, 2025 - 2035
Figure 66: Asia Pacific Nucleic Acid Therapeutics Market Value Share Analysis, By Route of Administration, 2024 and 2035
Figure 67: Asia Pacific Nucleic Acid Therapeutics Market Attractiveness Analysis, By Route of Administration, 2025 - 2035
Figure 68: Asia Pacific Nucleic Acid Therapeutics Market Value Share Analysis, By Therapeutic Area, 2024 and 2035
Figure 69: Asia Pacific Nucleic Acid Therapeutics Market Attractiveness Analysis, By Therapeutic Area, 2025 - 2035
Figure 70: Asia Pacific Nucleic Acid Therapeutics Market Value Share Analysis, By End-user, 2024 and 2035
Figure 71: Asia Pacific Nucleic Acid Therapeutics Market Attractiveness Analysis, By End-user, 2025 - 2035
Figure 72: Latin America Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, 2020 - 2035
Figure 73: Latin America Nucleic Acid Therapeutics Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
Figure 74: Latin America Nucleic Acid Therapeutics Market Attractiveness Analysis, by Country / Sub-region, 2025 - 2035
Figure 75: Latin America Nucleic Acid Therapeutics Market Value Share Analysis, By Therapy Type, 2024 and 2035
Figure 76: Latin America Nucleic Acid Therapeutics Market Attractiveness Analysis, By Therapy Type, 2025 - 2035
Figure 77: Latin America Nucleic Acid Therapeutics Market Value Share Analysis, By Delivery Method, 2024 and 2035
Figure 78: Latin America Nucleic Acid Therapeutics Market Attractiveness Analysis, By Delivery Method, 2025 - 2035
Figure 79: Latin America Nucleic Acid Therapeutics Market Value Share Analysis, By Route of Administration, 2024 and 2035
Figure 80: Latin America Nucleic Acid Therapeutics Market Attractiveness Analysis, By Route of Administration, 2025 - 2035
Figure 81: Latin America Nucleic Acid Therapeutics Market Value Share Analysis, By Therapeutic Area, 2024 and 2035
Figure 82: Latin America Nucleic Acid Therapeutics Market Attractiveness Analysis, By Therapeutic Area, 2025 - 2035
Figure 83: Latin America Nucleic Acid Therapeutics Market Value Share Analysis, By End-user, 2024 and 2035
Figure 84: Latin America Nucleic Acid Therapeutics Market Attractiveness Analysis, By End-user, 2025 - 2035
Figure 85: Middle East & Africa Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, 2020 - 2035
Figure 86: Middle East & Africa Nucleic Acid Therapeutics Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
Figure 87: Middle East & Africa Nucleic Acid Therapeutics Market Attractiveness Analysis, by Country / Sub-region, 2025 - 2035
Figure 88: Middle East & Africa Nucleic Acid Therapeutics Market Value Share Analysis, By Therapy Type, 2024 and 2035
Figure 89: Middle East & Africa Nucleic Acid Therapeutics Market Attractiveness Analysis, By Therapy Type, 2025 - 2035
Figure 90: Middle East & Africa Nucleic Acid Therapeutics Market Value Share Analysis, By Delivery Method, 2024 and 2035
Figure 91: Middle East & Africa Nucleic Acid Therapeutics Market Attractiveness Analysis, By Delivery Method, 2025 - 2035
Figure 92: Middle East & Africa Nucleic Acid Therapeutics Market Value Share Analysis, By Route of Administration, 2024 and 2035
Figure 93: Middle East & Africa Nucleic Acid Therapeutics Market Attractiveness Analysis, By Route of Administration, 2025 - 2035
Figure 94: Middle East & Africa Nucleic Acid Therapeutics Market Value Share Analysis, By Therapeutic Area, 2024 and 2035
Figure 95: Middle East & Africa Nucleic Acid Therapeutics Market Attractiveness Analysis, By Therapeutic Area, 2025 - 2035
Figure 96: Middle East & Africa Nucleic Acid Therapeutics Market Value Share Analysis, By End-user, 2024 and 2035
Figure 97: Middle East & Africa Nucleic Acid Therapeutics Market Attractiveness Analysis, By End-user, 2025 - 2035

Nucleic Acid Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035

Description

Table of Contents

List of Tables

Nucleic Acid Therapeutics Market - Scope of Report

Key Questions Answered in Global nucleic acid therapeutics market Report:

Nucleic Acid Therapeutics Market - Research Objectives and Research Approach

Table of Contents

1. Preface

2. Assumptions and Research Methodology

3. Executive Summary: Global Nucleic Acid Therapeutics Market

4. Market Overview

5. Key Insights

6. Global Nucleic Acid Therapeutics Market Analysis and Forecast, by Therapy Type

7. Global Nucleic Acid Therapeutics Market Analysis and Forecast, by Delivery Method

8. Global Nucleic Acid Therapeutics Market Analysis and Forecast, by Route of Administration

9. Global Nucleic Acid Therapeutics Market Analysis and Forecast, by Therapeutic Area

10. Global Nucleic Acid Therapeutics Market Analysis and Forecast, by End-user

11. Global Nucleic Acid Therapeutics Market Analysis and Forecast, by Region

12. North America Nucleic Acid Therapeutics Market Analysis and Forecast

13. Europe Nucleic Acid Therapeutics Market Analysis and Forecast

14. Asia Pacific Nucleic Acid Therapeutics Market Analysis and Forecast

15. Latin America Nucleic Acid Therapeutics Market Analysis and Forecast

16. Middle East & Africa Nucleic Acid Therapeutics Market Analysis and Forecast

17. Competition Landscape

List of Tables

List of Figures